The Zhitong Finance App learned that after being previously opposed by the US Food and Drug Administration (FDA), the influenza vaccine mFlusiva developed by Moderna (MRNA.US) was finally approved for marketing. This is certainly a major victory for the company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.